Domainex, Horizon Discovery Ltd. deal

Horizon and Domainex partnered to develop Domainex's TANK-binding kinase 1 (TBK1) and inhibitor of kappa light polypeptide gene enhancer in B cells kinase epsilon ( IKBKE; IKK-i) oncology research ...